Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: Fibre 1 (combined fibres);   Dietary Supplement: Fibre 2 (natural fibres);   Dietary Supplement: Dietary Supplement: placebo Sponsors:   King's College London;   Guy's and St Thomas' NHS Foundation Trust;   Universidad Veracruzana;   University of Liverpool Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2019 Category: Research Source Type: clinical trials

Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: MPH_active;   Dietary Supplement: MPH_placebo Sponsors:   Helse Møre og Romsdal HF;   Haukeland University Hospital;   University of Bergen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2019 Category: Research Source Type: clinical trials

Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
Conditions:   Irritable Bowel Syndrome;   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin;   Device: Glucose and lactulose hydrogen breath testing Sponsors:   University of Michigan;   Commonwealth Diagnostics International, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2018 Category: Research Source Type: clinical trials

A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Biological: MRx1234 [Blautia Hydrogenotrophica];   Other: Placebo Sponsor:   4DPharma PLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2018 Category: Research Source Type: clinical trials